Related Experiment Video
Updated: Apr 5, 2026

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
An Update on Cardiac Transplantation in the United States
Insights
Heart transplantation survival has improved, but allograft failure remains a challenge. Further innovations are crucial for enhancing long-term success in heart transplant recipients.
Area of Science:
- Cardiology
- Immunology
- Transplantation Medicine
Background:
- Heart transplantation is a vital treatment for end-stage heart failure in the United States.
- Survival rates have increased over 25 years due to immunosuppression, innovation, and risk management.
- Allograft failure persists as a significant complication post-transplantation.
Purpose of the Study:
- To highlight the current status and challenges in heart transplantation.
- To emphasize the need for advancements in managing allograft rejection.
- To underscore the importance of improving long-term outcomes for heart transplant patients.
Main Methods:
- This abstract is a review and does not detail specific experimental methods.
- It synthesizes existing knowledge on heart transplantation outcomes and challenges.
- Focuses on the clinical progression and complications following heart transplants.
Main Results:
- Survival rates following heart transplantation have shown considerable improvement.
- Despite advances, a substantial number of patients still face allograft failure.
- Current management strategies have limitations in preventing long-term complications.
Conclusions:
- Heart transplantation remains a critical therapy for heart failure.
- Reducing acute and chronic rejection is essential for better long-term graft survival.
- Continued innovation in immunosuppression and management is imperative for the future of heart transplantation.
Abstract:
Heart transplantation in the United States remains an important option for those with heart failure. Survival rates over the last 25 years have improved with the advent of newer immunosuppressive agents, innovation, and a better understanding of managing risk. However, many patients continue to experience allograft failure after transplantation. Innovations in modalities to reduce acute and chronic rejection are needed to improve the long-term success of heart transplantation.
Related Concept Videos
Kidney Transplant I: Introduction
Cardiomyopathy V: Interprofessional Care
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

